FdaApplication

NDA 211284

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCHARTWELL RX SCIENCES LLC
application_typeNDA
approval_date2018-11-16

Products (1)

ProductActive ingredientStrengthDosage form
TEMIXYSLAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE300MG;300MGTABLET;ORAL

1 product